{
    "clinical_study": {
        "@rank": "107547", 
        "acronym": "ADIBD", 
        "arm_group": [
            {
                "arm_group_label": "IBD patients on immunosuppression", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients on azathioprine/6-mercaptopurine (6MP), prednisone, methotrexate, infliximab, adalimumab, certolizumab, natalizumab, and etanercept are included."
            }, 
            {
                "arm_group_label": "IBD patients off immunosuppressants", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients off immunosuppressants, on 5-aminosalicylic acid (5-ASA) agents, antibiotics, or no treatment for IBD are included."
            }, 
            {
                "arm_group_label": "Healthy controls", 
                "arm_group_type": "Active Comparator", 
                "description": "Age-matched healthy controls enrolled from the hospital, outpatient clinics, and from the general public via flyers and online advertisements."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is designed to establish the prevalence of anal squamous intraepithelial lesion\n      (ASIL) in patients with inflammatory bowel disease (IBD) and healthy controls."
        }, 
        "brief_title": "Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Anal Squamous Intraepithelial Lesion (ASIL)", 
            "HPV DNA"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Inflammatory Bowel Diseases", 
                "Intestinal Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "IBD patients attending the Stanford Inflammatory Bowel Disease (IBD) clinic and age-matched\n      healthy controls are screened for eligibility. Informed consent is obtained for eligible\n      subjects. An anonymous self-administered questionnaire is administered to assess risk\n      factors for HPV. For IBD patients, information regarding IBD diagnosis and treatment is\n      obtained.\n\n      An anal pap smear is performed at the time of a clinic visit or at the time of an already\n      scheduled colonoscopy. Samples are collected and processed at Stanford pathology where a\n      blinded pathologist reads all specimens. Human Papillomavirus (HPV) DNA testing is performed\n      on all specimens.  All patients with anal squamous intraepithelial lesion (ASIL) are\n      referred to a colorectal surgeon for further recommendations or treatment, which includes a\n      high-resolution anoscopy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All IBD patients followed in the IBD clinic and healthy controls who are greater than\n             18 years old\n\n        Exclusion Criteria:\n\n          -  History of HPV vaccination\n\n          -  Pregnancy\n\n          -  Other immunosuppressed states (i.e. systemic lupus erythematosus, rheumatoid\n             arthritis, cancer, Human Immunodeficiency Virus (HIV), transplant)\n\n          -  IBD patients who don't meet immunosuppression/non-immunosuppression criteria\n\n          -  Inability to obtain informed consent from patient\n\n          -  Previous diagnosis of ASIL or anal/rectal cancer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "310", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860963", 
            "org_study_id": "MW-16467"
        }, 
        "intervention": {
            "arm_group_label": [
                "IBD patients on immunosuppression", 
                "IBD patients off immunosuppressants", 
                "Healthy controls"
            ], 
            "description": "Anal Pap smear is a standard diagnostic test used for early detection of pre-cancerous cells and anal HPV.", 
            "intervention_name": "Anal Pap smear and HPV DNA testing", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Immunosuppressive Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ASIL", 
            "Anal dysplasia", 
            "IBD", 
            "HPV DNA"
        ], 
        "lastchanged_date": "September 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stanford", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94305"
                }, 
                "name": "Stanford Digestive Health Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls", 
        "overall_official": [
            {
                "affiliation": "Stanford Hosptial and Clinics", 
                "last_name": "Mark Welton, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Stanford Hospital and Clinics", 
                "last_name": "Shamita Shah, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Presence of high risk HPV and/or abnormal cytology", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860963"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Stanford University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stanford University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}